Search Page

1

Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020.

Haveri A, Smura T, Kuivanen S, Österlund P, Hepojoki J, Ikonen N, Pitkäpaasi M, Blomqvist S, Rönkkö E, Kantele A, Strandin T, Kallio-Kokko H, Mannonen L, Lappalainen M, Broas M, Jiang M, Siira L, Salminen M, Puumalainen T, Sane J, Melin M, Vapalahti O, Savolainen-Kopra C. Haveri A, et al. Among authors: Kantele A. Euro Surveill. 2020 Mar;25(11):2000266. doi: 10.2807/1560-7917.ES.2020.25.11.2000266. Euro Surveill. 2020. PMID: 32209163 Free PMC article.

Cite

Share

2

Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level.

Woerther PL, Andremont A, Kantele A. Woerther PL, et al. Among authors: Kantele A. J Travel Med. 2017 Apr 1;24(suppl_1):S29-S34. doi: 10.1093/jtm/taw101. J Travel Med. 2017. PMID: 28520999 Free PMC article. Review.

Cite

Share

3

Novel activities of safe-in-human broad-spectrum antiviral agents.

Ianevski A, Zusinaite E, Kuivanen S, Strand M, Lysvand H, Teppor M, Kakkola L, Paavilainen H, Laajala M, Kallio-Kokko H, Valkonen M, Kantele A, Telling K, Lutsar I, Letjuka P, Metelitsa N, Oksenych V, Bjørås M, Nordbø SA, Dumpis U, Vitkauskiene A, Öhrmalm C, Bondeson K, Bergqvist A, Aittokallio T, Cox RJ, Evander M, Hukkanen V, Marjomaki V, Julkunen I, Vapalahti O, Tenson T, Merits A, Kainov D. Ianevski A, et al. Among authors: Kantele A. Antiviral Res. 2018 Jun;154:174-182. doi: 10.1016/j.antiviral.2018.04.016. Epub 2018 Apr 23. Antiviral Res. 2018. PMID: 29698664 Free PMC article. Review.

Cite

Share

4

Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.

Zuckerman JN, Hatz C, Kantele A. Zuckerman JN, et al. Among authors: Kantele A. Expert Rev Vaccines. 2017 Oct;16(10):1029-1043. doi: 10.1080/14760584.2017.1374861. Expert Rev Vaccines. 2017. PMID: 28856924 Review.

Cite

Share

5

The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis.

Erra EO, Kantele A. Erra EO, et al. Among authors: Kantele A. Expert Rev Vaccines. 2015;14(9):1167-79. doi: 10.1586/14760584.2015.1061939. Epub 2015 Jul 10. Expert Rev Vaccines. 2015. PMID: 26162529 Review.

Cite

Share

6

Circulating pathogen-specific plasmablasts in female patients with upper genital tract infection.

Palkola NV, Pakkanen SH, Heikinheimo O, Kantele JM, Kantele A. Palkola NV, et al. Among authors: Kantele JM, Kantele A. J Reprod Immunol. 2018 Apr;126:69-75. doi: 10.1016/j.jri.2018.02.005. Epub 2018 Mar 2. J Reprod Immunol. 2018. PMID: 29525428

Cite

Share

7

Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention.

Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, Zumla A. Petersen E, et al. Among authors: Kantele A. Infect Dis Clin North Am. 2019 Dec;33(4):1027-1043. doi: 10.1016/j.idc.2019.03.001. Epub 2019 Apr 11. Infect Dis Clin North Am. 2019. PMID: 30981594 Review.

Cite

Share

8

Travellers' diarrhoea: Impact of TD definition and control group design on study results.

Lääveri T, Pakkanen SH, Kirveskari J, Kantele A. Lääveri T, et al. Among authors: Kantele A. Travel Med Infect Dis. 2018 Jul-Aug;24:37-43. doi: 10.1016/j.tmaid.2018.01.006. Epub 2018 Feb 2. Travel Med Infect Dis. 2018. PMID: 29409749

Cite

Share

9

Systematic review of loperamide: No proof of antibiotics being superior to loperamide in treatment of mild/moderate travellers' diarrhoea.

Lääveri T, Sterne J, Rombo L, Kantele A. Lääveri T, et al. Among authors: Kantele A. Travel Med Infect Dis. 2016 Jul-Aug;14(4):299-312. doi: 10.1016/j.tmaid.2016.06.006. Epub 2016 Jun 27. Travel Med Infect Dis. 2016. PMID: 27363327 Free article. Review.

Cite

Share

10

Reply to Lauhio et al.

Kantele A, Lääveri T. Kantele A, et al. Clin Infect Dis. 2015 Sep 15;61(6):1031-2. doi: 10.1093/cid/civ503. Epub 2015 Jul 18. Clin Infect Dis. 2015. PMID: 26188208 No abstract available.

Cite

Share